Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function

被引:31
作者
Ngampasutadol, J
Rice, PA
Walsh, MT
Gulati, S
机构
[1] Boston Univ, Med Ctr, EBRC, Sect Infect Dis,Dept Med, Boston, MA 02118 USA
[2] Univ Massachusetts, Med Ctr, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA
[3] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA
关键词
oligosaccharide epitope; peptide vaccine candidate; immune response;
D O I
10.1016/j.vaccine.2005.07.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 2C7 epitope is a conserved oligosaccharide structure, a part of lipooligosaccharide (LOS) on Neisseria gonorrhoeae, present in 95% of clinical gonococcal isolates. 2C7 may represent a potential candidate for an anti-gonococcal vaccine. To circumvent the limitations of saccharide immunogens in producing long lived immune responses, we identified a peptide that mimics the 2C7 epitope using a random peptide library, characterizing linear and cyclic forms and formulating a multiple antigenic peptide. The multiple antigenic peptide Octa-MAP1 was used for immunization, and elicited >= 4-fold increase in cross-reactive anti-LOS antibodies in 26 of 30 mice (87%). IgG anti-LOS antibody elicited by Octa-MAP I immunization possessed dose-responsive direct complement (C)-dependent bactericidal activity against gonococcal strains that expressed the 2C7 epitope. These data indicate that a peptide can mimic an oligosaccharide epitope and may form the basis for the development of a vaccine candidate for human immunization against N. gonorrhoeae. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:157 / 170
页数:14
相关论文
共 49 条
[1]   BACTERICIDAL ANTIBODY-RESPONSE OF NORMAL HUMAN-SERUM TO THE LIPOOLIGOSACCHARIDE OF NEISSERIA-GONORRHOEAE [J].
APICELLA, MA ;
WESTERINK, MAJ ;
MORSE, SA ;
SCHNEIDER, H ;
RICE, PA ;
GRIFFISS, JM .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :520-526
[2]   SYNTHETIC VACCINES [J].
ARNON, R ;
SHAPIRA, M ;
JACOB, CO .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 61 (03) :261-273
[3]   Identification of the gene (lgtG) encoding the lipooligosaccharide β chain synthesizing glucosyl transferase from Neisseria gonorrhoeae [J].
Banerjee, A ;
Wang, R ;
Uljon, SN ;
Rice, PA ;
Gotschlich, EC ;
Stein, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10872-10877
[4]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[5]   A structure-based approach to a synthetic vaccine for HIV-1 [J].
Cabezas, E ;
Wang, M ;
Parren, PWHI ;
Stanfield, RL ;
Satterthwait, AC .
BIOCHEMISTRY, 2000, 39 (47) :14377-14391
[6]  
*CDC, 2000, STD SURV 2000, P15
[7]   Peptide mimics elicit antibody responses against the outer-membrane lipooligosaccharide of group B Neisseria meningitidis [J].
Charalambous, BM ;
Feavers, IM .
FEMS MICROBIOLOGY LETTERS, 2000, 191 (01) :45-50
[8]  
CHASE M, 1968, APPENDIX, V2, P389
[9]   PRODUCTION OF AN ATRIAL-NATRIURETIC-PEPTIDE VARIANT THAT IS SPECIFIC FOR TYPE-A RECEPTOR [J].
CUNNINGHAM, BC ;
LOWE, DG ;
LI, B ;
BENNETT, BD ;
WELLS, JA .
EMBO JOURNAL, 1994, 13 (11) :2508-2515
[10]   HUMAN VACCINATION WITH ESCHERICHIA-COLI J5 MUTANT INDUCES CROSS-REACTIVE BACTERICIDAL ANTIBODY AGAINST NEISSERIA-GONORRHOEAE LIPOOLIGOSACCHARIDE [J].
DALE, PA ;
MCQUILLEN, DP ;
GULATI, S ;
RICE, PA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :316-325